|
Whole Brain Radiotherapy (WBRT)
|
|
6
|
284
|
8 February 2026
|
|
Ribociclib side effects, scalp pain
|
|
8
|
1183
|
4 February 2026
|
|
Capecitabine lowered dose can it be raised again
|
|
1
|
84
|
4 February 2026
|
|
Have you received the treatment pertuzumab in combination with trastuzumab and docetaxel?
|
|
4
|
237
|
16 January 2026
|
|
Anyone on Enhertu?
|
|
5
|
6038
|
8 January 2026
|
|
Abemaciclib, any positives?
|
|
12
|
252
|
7 January 2026
|
|
Living with ONJ
|
|
1
|
164
|
7 January 2026
|
|
Fulvestrant problems
|
|
4
|
1001
|
5 January 2026
|
|
Flexible working request refused
|
|
17
|
861
|
1 January 2026
|
|
Travel advice
|
|
21
|
816
|
29 December 2025
|
|
Am I the only one with metastatic triple negative HER2neg in the bones?
|
|
3
|
344
|
9 December 2025
|
|
Libido loss
|
|
4
|
670
|
18 November 2025
|
|
Issues taking tamoxifen
|
|
2
|
188
|
13 November 2025
|
|
Brain met, surgery, SRS now Docetaxel & Phesgo
|
|
13
|
894
|
12 November 2025
|
|
Letrosole side effects
|
|
7
|
435
|
27 October 2025
|
|
Lobular Breast Cancer
|
|
16
|
4880
|
21 October 2025
|
|
Denosumab - itching?
|
|
4
|
217
|
21 October 2025
|
|
Help us shape our input into Scotland’s National Advisory Medicine Group (NCMAG) Programme review of the proposed use of paclitaxel in combination with pertuzumab and trastuzumab
|
|
0
|
58
|
3 October 2025
|
|
Fluid on lung
|
|
3
|
345
|
2 October 2025
|
|
Nephrostomy advice
|
|
8
|
245
|
30 September 2025
|
|
Paclitaxel reaction
|
|
7
|
345
|
28 September 2025
|
|
Breast Surgery for Triple Positive MBC
|
|
0
|
139
|
24 September 2025
|
|
Constant vomiting
|
|
25
|
1052
|
19 September 2025
|
|
Long term Herceptin patients
|
|
9
|
473
|
17 September 2025
|
|
Cryotherapy with topicals
|
|
1
|
109
|
16 September 2025
|
|
Drug SEs
|
|
3
|
379
|
18 August 2025
|
|
German clinics
|
|
31
|
9162
|
16 August 2025
|
|
Have you received capivasertib with fulvestrant?
|
|
1
|
371
|
31 July 2025
|
|
Lump in axilla
|
|
3
|
355
|
21 July 2025
|
|
Capecitabine tablets and swallowing
|
|
2
|
283
|
18 July 2025
|